Protective role of IL-2 during activation of T cells with bryostatin 1-Reference-Cited by-同舟云学术

Protective role of IL-2 during activation of T cells with bryostatin 1

Published:2000-08 Issue:8 Volume:22 Page:645-652
ISSN:0192-0561
Container-title:International Journal of Immunopharmacology
language:en
Short-container-title:International Journal of Immunopharmacology

Author:

Kos Ferdynand J.,Cornell David L.,Lipke Anne B.,Graham Laura J.,Bear Harry D.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology

Reference38 articles.

1. The bryostatins;Pettit,1991

2. Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity;Hornung;Cancer Res.,1992

3. Comparison of the antitumor activity of bryostatins 1, 5, and 8;Kraft;Cancer Chemother Pharmacol,1996

4. Immunomodulating properties of a novel series of protein kinase C activators. The bryostatins;Trenn;J. Immunol.,1988

5. Activation of human T lymphocytes by bryostatin;Hess;J. Immunol.,1988

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adoptive immunotherapy with cells from tumor-draining lymph nodes activated and expanded in vitro;Methods in Cell Biology;2023

2. A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma;Investigational New Drugs;2006-02-28

3. Bryostatin-1: A Novel PKC Inhibitor in Clinical Development;Cancer Investigation;2003-01

4. BIOSYNTHETIC PRODUCTS FOR ANTICANCER DRUG DESIGN AND TREATMENT: THE BRYOSTATINS;Anticancer Drug Development;2002

5. The role of prolactin in systemic lupus erythematosus;NeuroImmune Biology;2001